Vincent Serra
Chief Operating Officer at NEOVACS
Vincent Serra active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NEOVACS | Chief Tech/Sci/R&D Officer | - | - |
| Chief Operating Officer | - | - | |
| Chief Executive Officer | - | - | |
| BioSupport AG | Corporate Officer/Principal | - | - |
Career history of Vincent Serra
Former positions of Vincent Serra
| Companies | Position | Start | End |
|---|---|---|---|
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Chief Executive Officer | 01/08/2005 | 01/02/2014 |
| Chief Tech/Sci/R&D Officer | 01/08/2005 | 01/02/2014 | |
| Founder | 22/12/2009 | 01/02/2014 | |
Anosys, Inc.
 Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Corporate Officer/Principal | 03/01/1999 | 01/02/2005 |
| ABIVAX | Corporate Officer/Principal | - | - |
Training of Vincent Serra
| University of Grenoble | Doctorate Degree |
Statistics
International
| France | 4 |
| United States | 2 |
| 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| NEOVACS | Health Technology |
| ABIVAX | Health Technology |
| Private companies | 3 |
|---|---|
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Health Technology |
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
| BioSupport AG |
- Stock Market
- Insiders
- Vincent Serra
- Experience